S.A. Dudley

Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer

Ben Y. Durkee, Yushen Qian, Erqi L. Pollom et al. · Journal of Clinical Oncology · 2015 · 118 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data

Michael F. Gensheimer, A. Solomon Henry, Douglas Wood et al. · JNCI Journal of the National Cancer Institute · 2018 · 54 citations · Full text

Computing, Biomedical Informatics, Health Informatics +17

Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of Gabapentin

Wuyang Yang, Todd McNutt, S.A. Dudley et al. · Dysphagia · 2016 · 42 citations

Medicine, Oncology, Radiation Oncology +15

A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

Hamza Hasan, Matthew P. Deek, Ryan Phillips et al. · BMC Cancer · 2020 · 32 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR)

Aadel A. Chaudhuri, Michael S. Binkley, Joseph Rigdon et al. · Radiotherapy and Oncology · 2016 · 28 citations

Medicine, Nuclear Medicine, Oncology +12